NASDAQ:BHST · NASDAQ Global Market
+$0.08 today
Vol 0.01M · Avg 0.03M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of BioHarvest Sciences Inc. Common Stock earnings power becomes long-term shareholder value. Use this page to compare BHST returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
-43.8%
avg -71.0%
ROIC
-13.4%
avg -26.1%
ROA
-23.4%
avg -69.2%
Analysis
ROIC is currently the strongest return metric at -13.4% versus its period average of -26.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Zaki Rakib | Co-Founder, CEO, Executive Chairman & President | $499,200.00 | — | 67 | — | — |
Ilan Sobel | Chief Executive Officer | $470,223.00 | — | — | — | — |
Yoheved Hagay | Co-Founder & CTO | $349,567.00 | — | 68 | — | — |
Ilana Belzer | Chief Operating Officer | $315,197.00 | — | 66 | — | — |
Jared Turner | Chief Sales Officer | $298,000.00 | — | — | — | — |
Malkit Azachi | Vice President of Research & Development | $214,339.00 | — | — | — | — |
Michal Abargel Sapir | Vice President of Regulatory Affairs | $185,233.00 | — | — | — | — |
Bar Dichter | Chief Financial Officer | $181,110.00 | — | — | — | — |
David K. Ryan | Vice President of Investor Relations & Secretary | $42,781.00 | — | 59 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
TRX Gold Corporation
AMEX:TRX
$296.96M
Friedman Industries, Incorporated
NASDAQ:FRD
$262.09M
Core Molding Technologies, Inc.
AMEX:CMT
$210.43M
FutureFuel Corp.
NYSE:FF
$186.86M
Ascent Industries Co.
NASDAQ:ACNT
$126.04M
U.S. GoldMining Inc.
NASDAQ:USGO
$110.31M
American Vanguard Corporation
NYSE:AVD
$74.66M
Mercer International Inc.
NASDAQ:MERC
$58.21M
Who manages BHST?
BioHarvest Sciences Inc. Common Stock (BHST) lists 9 active executives. The top listed executive is Yoheved Hagay, Co-Founder & CTO.
Explore More
Continue the stock analysis
Jump to another research area for this company.